Associate Director Marketing, PDAC at Revolution Medicines | USA | $177K/yr – $221K/yr

Revolution Medicines

Associate Director Marketing, PDAC

USA (Hybrid)

$177K/yr – $221K/yrSenior Level10+ years expFull time

Posted 3 months ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Drive oncology brand strategy and launch execution, leading cross-functional efforts for Revolution Medicines.

Own development and execution of brand/launch strategies across channels.
Must-have: 10+ years in biotech/pharma marketing with omnichannel experience.
Standout: Leadership of cross-functional launch workstreams and agency relationships.

Job Description

Responsibilities

Operate as an ambassador of the company, establishing the organization as trusted member of the healthcare community to all relevant stakeholders.
Lead the development of effective strategic and promotional plans, shape launch strategy to align with full brand and portfolio strategy.
Leverage deep understanding of oncology healthcare customers, including providers, key opinion leaders, patients, and market access stakeholders, to inform the brand strategic approach that drives customer behavior change and market performance.
Lead implementation of brand/launch strategies through development of effective promotional materials for key customer segments (e.g., HCPs, patients, KOLs, allied health professionals, market access stakeholders) and across multiple channels.
Lead critical cross functional workstreams to support launch readiness and success.
Leverage insights to inform stakeholder segmentation, channel mix, and targeting of customer segments.
Ensure tactical execution is aligned to brand/launch strategies and stakeholder insights.
Maintain deep knowledge of disease state, competitive, and market dynamics, informing potential pivots in strategic and executional approach as needed.
Partner with internal stakeholders to develop and deliver impactful customer-facing content.
Partner with Analytics & Insights to shape market research, inform key performance metrics, and measure the effectiveness of marketing initiatives.

Requirements

Bachelor’s degree required with at least 10 years of progressive commercial experience in a biotechnology and/or pharmaceutical company including strategic marketing and omnichannel marketing.
Strong leadership skills, with the ability to work well cross-functionally and influence across an organization at all levels.
Proven track record of developing and executing effective marketing initiatives.
Demonstrated analytical and problem-solving skills, leading to the development of innovative marketing initiatives.
Excellent organizational skills and an ability to prioritize effectively to deliver results within reasonably established timelines.
Strong interpersonal skills, with demonstrated ability to lead and influence cross-functional partners.
Exceptional communication skills, including excellent written and verbal communication skills; possesses a professional, proactive demeanor.
Entrepreneurial mindset, with a tolerance for ambiguity, and a passion for helping cancer patient.
Ability to represent Revolution Medicines well externally.

Preferred

MBA.
Launch and customer-facing experience.
Experience with targeted oncology products.
Experience in a smaller, rapidly growing, company.

Benefits

competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.

Revolution Medicines

3.5 Glassdoor

We are Revolutionaries – passionate in our singular pursuit of discovering, developing and delivering innovative, targeted medicines for patients living with cancer. To deliver on our vision, we work relentlessly in pursuit of cutting-edge therapeutic approaches to some of the toughest cancers. Our current focus is on RAS-addicted cancers, which account for 30 percent of all new human cancer diagnoses.

Founded in 2014

Redwood City, California, USA

817 employees (26 in marketing)

www.revmed.com

54% recommend to a friend

64% CEO approval